A citation-based method for searching scientific literature

Chao Jin, Xiaonan Liu, Wenyuan Zheng, Liping Su, Yang Liu, Xu Guo, Xiaoming Gu, Hongping Li, Bo Xu, Gang Wang, Jiyan Yu, Qiong Zhang, Dengke Bao, Shaogui Wan, Fei Xu, Xiaohuan Lai, Jiayun Liu, Jinliang Xing. Mol Oncol 2021
Times Cited: 3







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation.
Peiyong Jiang, Kun Sun, Wenlei Peng, Suk Hang Cheng, Meng Ni, Philip C Yeung, Macy M S Heung, Tingting Xie, Huimin Shang, Ze Zhou,[...]. Cancer Discov 2020
60
100

Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
Yu-Jing Zhang, Hui-Chen Wu, Jing Shen, Habibul Ahsan, Wei Yann Tsai, Hwai-I Yang, Li-Yu Wang, Shu-Yuan Chen, Chien-Jen Chen, Regina M Santella. Clin Cancer Res 2007
144
66

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
Peiyong Jiang, Carol W M Chan, K C Allen Chan, Suk Hang Cheng, John Wong, Vincent Wai-Sun Wong, Grace L H Wong, Stephen L Chan, Tony S K Mok, Henry L Y Chan,[...]. Proc Natl Acad Sci U S A 2015
383
66

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma.
Baoliang Li, Hao Huang, Ronghai Huang, Wei Zhang, Guangpeng Zhou, Zhen Wu, Chunhua Lv, Xiaoliang Han, Li Jiang, Yongjun Li,[...]. Dis Markers 2020
6
66

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
Jiabin Cai, Lei Chen, Zhou Zhang, Xinyu Zhang, Xingyu Lu, Weiwei Liu, Guoming Shi, Yang Ge, Pingting Gao, Yuan Yang,[...]. Gut 2019
113
66

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
John B Kisiel, Brian A Dukek, Reddappa V S R Kanipakam, Hassan M Ghoz, Tracy C Yab, Calise K Berger, William R Taylor, Patrick H Foote, Nasra H Giama, Kristeen Onyirioha,[...]. Hepatology 2019
75
66

Liquid biopsy enters the clinic - implementation issues and future challenges.
Michail Ignatiadis, George W Sledge, Stefanie S Jeffrey. Nat Rev Clin Oncol 2021
250
66


High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Winnie Yeo, Nathalie Wong, Wai-Lap Wong, Paul B S Lai, Sheng Zhong, Philip J Johnson. Liver Int 2005
83
66

Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D Brenton, Carlos Caldas, Simon Pacey, Richard Baird, Nitzan Rosenfeld. Nat Rev Cancer 2017
66


Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
Abderrahim Oussalah, Susann Rischer, Mouni Bensenane, Guillaume Conroy, Pierre Filhine-Tresarrieu, Renée Debard, Denise Forest-Tramoy, Thomas Josse, Dana Reinicke, Matthieu Garcia,[...]. EBioMedicine 2018
75
66

Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.
Peiyong Jiang, Kun Sun, Yu K Tong, Suk Hang Cheng, Timothy H T Cheng, Macy M S Heung, John Wong, Vincent W S Wong, Henry L Y Chan, K C Allen Chan,[...]. Proc Natl Acad Sci U S A 2018
85
66

Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study.
Jörn Lewin, Denise Kottwitz, Johanna Aoyama, Theo deVos, Jorge Garces, Oliver Hasinger, Stefanie Kasielke, Florian Knaust, Preeti Rathi, Sebastian Rausch,[...]. BMC Gastroenterol 2021
6
66

Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR.
Juan Wang, Liu Yang, Yanjun Diao, Jiayun Liu, Jinjie Li, Rui Li, Lianghong Zheng, Kang Zhang, Yueyun Ma, Xiaoke Hao. J Int Med Res 2021
3
66

Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.
Hui-Chen Wu, Hwai-I Yang, Qiao Wang, Chien-Jen Chen, Regina M Santella. Carcinogenesis 2017
24
66

Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and α-Fetoprotein.
Zuowei Meng, Qingqi Ren, Guolin Zhong, Shiyong Li, Yan Chen, Wei Wu, Yumin Feng, Mao Mao, Feng Zhang, Guanghui Long. J Mol Diagn 2021
5
66

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release.
M Stroun, J Lyautey, C Lederrey, A Olson-Sand, P Anker. Clin Chim Acta 2001
510
66

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.
C K Y Ng, G G Di Costanzo, N Tosti, V Paradiso, M Coto-Llerena, G Roscigno, V Perrina, C Quintavalle, T Boldanova, S Wieland,[...]. Ann Oncol 2018
53
33

What do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?
Reyes Bernabé, Nicholas Hickson, Andrew Wallace, Fiona Helen Blackhall. Eur J Cancer 2017
41
33

Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment.
Linghui Zhou, Houli Zhao, Yang Shao, Xin Chen, Ruimin Hong, Linqin Wang, Fang Ni, Arnon Nagler, Yongxian Hu, He Huang. J Cancer 2021
3
33


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Mol Cancer 2019
122
33

Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
Johann von Felden, Amanda J Craig, Teresa Garcia-Lezana, Ismail Labgaa, Philipp K Haber, Delia D'Avola, Amon Asgharpour, Douglas Dieterich, Antoinette Bonaccorso, Miguel Torres-Martin,[...]. Oncogene 2021
42
33

Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
Jessica Howell, Stephen R Atkinson, David J Pinato, Susanne Knapp, Caroline Ward, Rosalba Minisini, Michela E Burlone, Monica Leutner, Mario Pirisi, Reinhard Büttner,[...]. Eur J Cancer 2019
27
33

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma.
Jian Wang, Ao Huang, Yu-Peng Wang, Yue Yin, Pei-Yao Fu, Xin Zhang, Jian Zhou. Ann Transl Med 2020
19
33

The pre-analytical phase of the liquid biopsy.
Francesca Salvianti, Stefania Gelmini, Filomena Costanza, Irene Mancini, Gemma Sonnati, Lisa Simi, Mario Pazzagli, Pamela Pinzani. N Biotechnol 2020
31
33

Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients.
Priyanka Iyer, Abdel-Rahman Zekri, Chu-Wei Hung, Emily Schiefelbein, Kadry Ismail, Ahmed Hablas, Ibrahim A Seifeldin, Amr S Soliman. Exp Mol Pathol 2010
59
33

Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma.
Yu Xiong, Cheng-Rong Xie, Sheng Zhang, Jin Chen, Zhen-Yu Yin. Cancer Manag Res 2019
13
33

Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Haikun Zhang, Peiling Dong, Shicheng Guo, Chengcheng Tao, Wei Chen, Wenmin Zhao, Jiakang Wang, Ramsey Cheung, Augusto Villanueva, Jian Fan,[...]. BMC Med 2020
15
33

Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients.
Lu Wen, Jingyi Li, Huahu Guo, Xiaomeng Liu, Shengmin Zheng, Dafang Zhang, Weihua Zhu, Jianhui Qu, Limin Guo, Dexiao Du,[...]. Cell Res 2015
55
33

Comparison of Roche Cell-Free DNA collection Tubes ® to Streck Cell-Free DNA BCT ® s for sample stability using healthy volunteers.
Sarah Parackal, Donghui Zou, Robert Day, Michael Black, Parry Guilford. Pract Lab Med 2019
10
33

The role of telomeres and telomerase in cirrhosis and liver cancer.
Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, Jessica Zucman-Rossi. Nat Rev Gastroenterol Hepatol 2019
91
33

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.
Michael L Cheng, Eirini Pectasides, Glenn J Hanna, Heather A Parsons, Atish D Choudhury, Geoffrey R Oxnard. CA Cancer J Clin 2021
53
33

NGS-based accurate and efficient detection of circulating cell-free mitochondrial DNA in cancer patients.
Yang Liu, Kaixiang Zhou, Shanshan Guo, Yang Wang, Xiaoying Ji, Qing Yuan, Liping Su, Xu Guo, Xiwen Gu, Jinliang Xing. Mol Ther Nucleic Acids 2021
10
33

Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Rita Lampignano, Martin H D Neumann, Sabrina Weber, Vera Kloten, Andrei Herdean, Thorsten Voss, Daniel Groelz, Anna Babayan, Marco Tibbesma, Martin Schlumpberger,[...]. Clin Chem 2020
66
33

Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments.
Yang Wang, Kaixiang Zhou, Xiangxu Wang, Yang Liu, Dongnan Guo, Zhenyuan Bian, Liping Su, Kun Liu, Xiwen Gu, Xu Guo,[...]. Cancer Sci 2021
2
50

Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.
Lei Chen, Ghassan K Abou-Alfa, Bo Zheng, Jing-Feng Liu, Jian Bai, Lu-Tao Du, Yun-Song Qian, Rong Fan, Xiao-Long Liu, Lin Wu,[...]. Cell Res 2021
19
33

External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants.
Sze Yee Chai, Rongxue Peng, Rui Zhang, Li Zhou, Nalishia Pillay, Kwang Hong Tay, Tony Badrick, Jinming Li, Martin P Horan. Pathol Oncol Res 2020
3
33

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma.
Ho Yeong Lim, Philippe Merle, Karl Heinz Weiss, Thomas Yau, Paul Ross, Vincenzo Mazzaferro, Jean-Frédéric Blanc, Yuk Ting Ma, Chia Jui Yen, Judit Kocsis,[...]. Clin Cancer Res 2018
40
33

The septin family of GTPases: architecture and dynamics.
Christine S Weirich, Jan P Erzberger, Yves Barral. Nat Rev Mol Cell Biol 2008
243
33

Combination treatment for advanced hepatocellular carcinoma with portal vein tumour thrombus: A case report.
Jianrong Wang, Junxue Wang, Jianzhu Wang, Ziliang Qian, Wensheng Xu, Xiaofeng Hang. J Int Med Res 2021
1
100

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study.
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, Fiona Thistlethwaite, Louise Carter, Emma Dean, Nigel Smith, Shaun Villa, Joanne Dransfield, Alexandra Clipson,[...]. Nat Med 2019
139
33


Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
Ahmed O Kaseb, Nora S Sánchez, Shiraj Sen, Robin K Kelley, Benjamin Tan, Andrea G Bocobo, Kian H Lim, Reham Abdel-Wahab, Marc Uemura, Roberto Carmagnani Pestana,[...]. Clin Cancer Res 2019
40
33

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.
Christian Rolfo, Philip C Mack, Giorgio V Scagliotti, Paul Baas, Fabrice Barlesi, Trever G Bivona, Roy S Herbst, Tony S Mok, Nir Peled, Robert Pirker,[...]. J Thorac Oncol 2018
356
33





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.